These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 12798395

  • 1. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer.
    Mohan S, Epstein JB.
    Oral Oncol; 2003 Sep; 39(6):537-46. PubMed ID: 12798395
    [Abstract] [Full Text] [Related]

  • 2. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 3. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
    Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM.
    Clin Cancer Res; 2004 Sep 01; 10(17):5930-9. PubMed ID: 15355926
    [Abstract] [Full Text] [Related]

  • 4. COX-2 inhibition in upper aerodigestive tract tumors.
    Altorki NK, Subbaramaiah K, Dannenberg AJ.
    Semin Oncol; 2004 Apr 01; 31(2 Suppl 7):30-6. PubMed ID: 15252927
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib.
    Nishimura N, Urade M, Hashitani S, Noguchi K, Manno Y, Takaoka K, Sakurai K.
    J Oral Pathol Med; 2004 Nov 01; 33(10):614-21. PubMed ID: 15482328
    [Abstract] [Full Text] [Related]

  • 9. Selective COX-2 inhibitors as chemopreventive and therapeutic agents.
    Grossman HB.
    Drugs Today (Barc); 2003 Mar 01; 39(3):203-12. PubMed ID: 12730704
    [Abstract] [Full Text] [Related]

  • 10. The role of COX-2 inhibition in breast cancer treatment and prevention.
    Arun B, Goss P.
    Semin Oncol; 2004 Apr 01; 31(2 Suppl 7):22-9. PubMed ID: 15179621
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.
    Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO.
    Head Neck; 2002 Aug 01; 24(8):792-9. PubMed ID: 12203806
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib with chemotherapy in colorectal cancer.
    Blanke CD.
    Oncology (Williston Park); 2002 Apr 01; 16(4 Suppl 3):17-21. PubMed ID: 12014863
    [Abstract] [Full Text] [Related]

  • 13. The role of COX-2 in oral cancer development, and chemoprevention/ treatment of oral cancer by selective COX-2 inhibitors.
    Wang Z.
    Curr Pharm Des; 2005 Apr 01; 11(14):1771-7. PubMed ID: 15892674
    [Abstract] [Full Text] [Related]

  • 14. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    Scand J Rheumatol Suppl; 1999 Apr 01; 109():31-7. PubMed ID: 10422544
    [Abstract] [Full Text] [Related]

  • 15. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z, Milas L, Komaki R, Stevens C, Cox JD.
    Am J Clin Oncol; 2003 Aug 01; 26(4):S85-91. PubMed ID: 12902863
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.
    Dannenberg AJ, Altorki NK, Boyle JO, Lin DT, Subbaramaiah K.
    Ann N Y Acad Sci; 2001 Dec 01; 952():109-15. PubMed ID: 11795429
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
    Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.
    JAMA; 1999 Nov 24; 282(20):1921-8. PubMed ID: 10580457
    [Abstract] [Full Text] [Related]

  • 18. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    J Rheumatol Suppl; 1999 Apr 24; 56():31-6. PubMed ID: 10225538
    [Abstract] [Full Text] [Related]

  • 19. COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs.
    Moore BC, Simmons DL.
    Curr Med Chem; 2000 Nov 24; 7(11):1131-44. PubMed ID: 11032963
    [Abstract] [Full Text] [Related]

  • 20. COX-2 inhibition and lung cancer.
    Sandler AB, Dubinett SM.
    Semin Oncol; 2004 Apr 24; 31(2 Suppl 7):45-52. PubMed ID: 15179623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.